Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
CI-1033 (Canertinib)
Cat No.
CEI-0076
Description
CI-1033 (Canertinib) can inhibit EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM.
Alias
PD-183805
CAS No.
267243-28-7
Molecular Weight
485.94
Purity
>99%
Storage
2 years at -20centigrade Powder
Synonyms
PD-183805
Targets
EGFR, ErbB2
Molecular Formula
C24H25ClFN5O3
Chemical Name
N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
Solubility
DMSO 2 mg/mL Water
In vitro
CI-1033 is an irreversible pan ErbB tyrosine kinase inhibitor, and CI-1033 inhibit all four members of the erbB receptor tyrosine kinase family by binding to the ATP-binding site in the cytoplasmic domain of the EGFR preventing autophosphorylation. CI-1033 inhibits cell proliferation in a dose-dependent manner without induction of apoptosis in human cancer cell lines. CI-1033 signi?cantly suppresses the constitutively activated AKT and the MAP kinases in MDA-MB-453 breast tumor cells.
In vivo
CI-1033 had a growth-inhibitory effect in breast cancer cells, and exposure of SUM-190PT cells to gamma ray irradiation following growth inhibition by CI-1033 enhanced the ef?cacy of ionizing radiation.
Download
Download Datasheet